02315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 61.25
+0.25%Margins
Gross margin
77.1%
EBITDA margin
34.4%
EBIT margin
26.0%
Net margin
21.5%
FCF margin
8.1%
15.1%
Return on equity
10.1%
Return on assets
13.4%
Return on invested capital
0.46x
Asset turnover
HKD 480.4M
Cash from operations
HKD 3.03
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026